Please login to the form below

Not currently logged in
Email:
Password:

Insmed appoints FDA's Dr Eugene Sullivan

He joinsthe US biopharmaceutical firm as its chief medical officer

US biopharmaceutical company Insmed has appointed former deputy director of the FDA Dr Eugene Sullivan to be its new chief medical and scientific officer.

Dr Sullivan was most recently vice president of global regulatory affairs at AstraZeneca and prior to that, during a career that has so far spanned more than 20 years focusing on pulmonary and orphan diseases, served at United Therapeutics.

He also spent a seven-year spell from 1999 at the FDA, where he held several positions, including deputy director of its Pulmonary and Allergy Products division.

In his new role Dr Sullivan will report to Will Lewis, president and chief executive officer, who said: “Gene is actively involved as an author, lecturer and advisor on medical and regulatory matters affecting orphan drugs and pulmonary diseases.

“His experience will provide new insight and valuable perspective as we advance Arikayce, INS1009 and our other pipeline candidates while building Insmed into a leading biopharmaceutical company.”

30th March 2015

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
ROAD

ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...